GGrantIndex
← Leaderboards

Weihang Chai

Loyola University Chicago

$6,849,592
Attributed
$6,849,592
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,849,592 · 10

By mechanism

R01$4,860,483 · 3
R21$834,219 · 2
R15$525,694 · 2
R56$377,500 · 1
R03$153,000 · 1
F32$98,696 · 1

Top collaborators

No co-investigators on record.

Most similar at Loyola University Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Prevent

Research focus

PreventInsightGenome StabilityResponseProteinsComplexCellsGenomic InstabilityBiochemicalMalignant NeoplasmsMaintenancePathway InteractionsDna BiosynthesisSiteGenome IntegrityFunctional DisorderAgingMediatingEventGenomeMolecularBindingDesignDna Damage

Grant awards (32)

Molecular Basis of Coats Plus Disease$400,847
R01 · FY2025 · GM · contact PI
Molecular modulator of RAD51 in maintaining genome stability$388,830
R01 · FY2025 · CA · contact PI
Molecular Basis of Coats Plus Disease$400,847
R01 · FY2024 · GM · contact PI
Molecular Basis of Coats Plus Disease$108,491
R01 · FY2024 · GM · contact PI
Molecular Basis of Coats Plus Disease$1
R01 · FY2024 · GM · contact PI
Molecular Basis of Coats Plus Disease$390,946
R01 · FY2023 · GM · contact PI
Identification of a novel tumor suppressor of melanoma and UV-induced genome instability$236,850
R21 · FY2023 · ES · contact PI
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability$214,232
R01 · FY2023 · CA · contact PI
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability$115,000
R01 · FY2023 · CA · contact PI
Molecular Basis of Coats Plus Disease$45,146
R01 · FY2023 · GM · contact PI
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability$329,232
R01 · FY2022 · CA · contact PI
Identification of a novel tumor suppressorof melanoma and UV-induced genome instability$192,500
R21 · FY2022 · ES · contact PI
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability$335,406
R01 · FY2021 · CA · contact PI
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability$333,769
R01 · FY2020 · CA · contact PI
Molecular Modulator of RPA and RAD51 in Maintaining Genome Stability$245,080
R01 · FY2019 · CA · contact PI
Molecular modulator of RPA and RAD51 in maintaining genome stability$98,277
R01 · FY2019 · CA · contact PI
Role of telomerase in DSB repair$60,541
R03 · FY2019 · CA · contact PI
Role of Telomerase is DSB Repair$15,959
R03 · FY2019 · CA · contact PI
Mechanisms of fork restart in response to genotoxic stress$238,717
R01 · FY2018 · GM · contact PI
Role of telomerase in DSB repair$76,500
R03 · FY2018 · CA · contact PI
Mechanisms of Fork Restart in Response to Genotoxic Stress$52,962
R01 · FY2018 · GM · contact PI
Mechanisms of fork restart in response to genotoxic stress$290,675
R01 · FY2017 · GM · contact PI
Mechanisms of fork restart in response to genotoxic stress$290,675
R01 · FY2016 · GM · contact PI
Role of human CST in preventing telomere loss$377,500
R56 · FY2015 · AG · contact PI
Mechanisms of fork restart in response to genotoxic stress$290,675
R01 · FY2015 · GM · contact PI
Mechanisms of fork restart in response to genotoxic stress$290,675
R01 · FY2014 · GM · contact PI
Investigation into Mechanisms of CDK1 in Controlling Telomere Stability$178,369
R21 · FY2013 · AG · contact PI
Investigation into Mechanisms of CDK1 in Controlling Telomere Stability$226,500
R21 · FY2012 · AG · contact PI
Mechanism for Telomeric G-overhang Generation in Human Cells$301,444
R15 · FY2011 · GM · contact PI
Function of human FEN1 in telomere maintenance$224,250
R15 · FY2008 · CA · contact PI
Regulation of the rate of human telomere shortening$50,548
F32 · FY2004 · GM
Regulation of the rate of human telomere shortening$48,148
F32 · FY2003 · GM